Nebula Research & Development’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,839
Closed -$1.17M 13
2025
Q2
$1.17M Sell
16,839
-2,928
-15% -$167K 0.1% 345
2025
Q1
$982K Buy
19,767
+11,755
+147% +$743K 0.09% 381
2024
Q4
$560K Buy
+8,012
New +$665K 0.07% 513
2024
Q3
Sell
-2,383
Closed -$339K 907
2024
Q2
$339K Sell
2,383
-483
-17% -$55.7K 0.05% 566
2024
Q1
$320K Sell
2,866
-7,350
-72% -$876K 0.07% 510
2023
Q4
$1.32M Buy
10,216
+5,297
+108% +$730K 0.4% 45
2023
Q3
$802K Buy
+4,919
New +$865K 0.42% 41

Other funds holding ACLS

Nebula Research & Development's ACLS Position: Q3 2025 in Review

Nebula Research & Development sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 16,839 shares — an estimated $1.17M sold.

Nebula Research & Development first reported a position in ACLS in Q3 2023 and held it in 7 quarters. The position peaked at $1.32M in Q4 2023. 360 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • Nebula Research & Development reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 16,839 Axcelis shares in Q3 2025, an estimated $1.17M.
  • Nebula Research & Development first reported a position in Axcelis in Q3 2023 and held it in 7 quarters.
  • Nebula Research & Development's Axcelis position peaked at $1.32M in Q4 2023.
  • 360 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.